Turk J Med Sci:糠酸莫米松鼻喷雾剂对鼻粘膜细胞DNA影响研究

2018-05-10 AlexYang MedSci原创

过敏性鼻炎(AR)是一种呼吸道疾病,并且是由鼻粘膜炎症引起。鼻用糖皮质激素(ICs)在治疗AR方面是非常有效的;然而,这些药物的使用与鼻粘膜萎缩相关。因为DNA损伤与一些慢性疾病有关联。最近,有研究人员提出这样的一个假设,即ICs的使用能够引起鼻粘膜细胞的DNA损伤,从而导致鼻萎缩和鼻中隔穿孔。研究包括了60名患有中度或者重度AR的患者,研究人员将其随机分成2个小组。糠酸莫米他松(MF)和抗组胺药

过敏性鼻炎(AR)是一种呼吸道疾病,并且是由鼻粘膜炎症引起。鼻用糖皮质激素(ICs)在治疗AR方面是非常有效的;然而,这些药物的使用与鼻粘膜萎缩相关。因为DNA损伤与一些慢性疾病有关联。最近,有研究人员提出这样的一个假设,即ICs的使用能够引起鼻粘膜细胞的DNA损伤,从而导致鼻萎缩和鼻中隔穿孔。

研究包括了60名患有中度或者重度AR的患者,研究人员将其随机分成2个小组。糠酸莫米他松(MF)和抗组胺药片(地氯雷他定)在研究组(IC)中使用。生理盐水和地氯雷他定在对照组(血清生理(SP))中使用。另外,研究人员还在研究开始和治疗4周后对洗鼻液进行了采样,并进行了鼻粘膜DNA损伤鉴定。研究发现总共排除了19名患者,最后研究包括了41名患者(IC组:17名患者;SP组:24名患者),并通过彗星试验对遗传毒性损伤进行了鉴定。

研究人员指出,MF喷雾为期4周的治疗并没有引起鼻粘膜细胞内的DNA损伤。最后,研究人员指出,这些结果能够形成有关不同ICs长期治疗的临床试验基础。

原始出处:

Akkas H, Aydin E, Türkoglu Babakurban S et al. Effect of mometasone furoate nasal spray on the DNA of nasal mucosal cells. Turk J Med Sci. 30 April 2018.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1676073, encodeId=95c616e60734c, content=<a href='/topic/show?id=3e7c8e9884c' target=_blank style='color:#2F92EE;'>#莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87988, encryptionId=3e7c8e9884c, topicName=莫米松)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b227313875, createdName=listen327, createdTime=Tue Oct 23 21:09:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994937, encodeId=9083199493ee4, content=<a href='/topic/show?id=3a05103496c1' target=_blank style='color:#2F92EE;'>#鼻粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103496, encryptionId=3a05103496c1, topicName=鼻粘膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Wed Aug 08 09:09:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041983, encodeId=1669204198376, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103432, encryptionId=987b103432fe, topicName=鼻喷雾剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 01 09:09:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690991, encodeId=73001690991bd, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Thu Feb 28 02:09:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804343, encodeId=7b041804343c9, content=<a href='/topic/show?id=72e4e688685' target=_blank style='color:#2F92EE;'>#糠酸莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76886, encryptionId=72e4e688685, topicName=糠酸莫米松)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Sat Jul 14 07:09:00 CST 2018, time=2018-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608815, encodeId=5d0916088150a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 12 11:09:00 CST 2018, time=2018-05-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1676073, encodeId=95c616e60734c, content=<a href='/topic/show?id=3e7c8e9884c' target=_blank style='color:#2F92EE;'>#莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87988, encryptionId=3e7c8e9884c, topicName=莫米松)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b227313875, createdName=listen327, createdTime=Tue Oct 23 21:09:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994937, encodeId=9083199493ee4, content=<a href='/topic/show?id=3a05103496c1' target=_blank style='color:#2F92EE;'>#鼻粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103496, encryptionId=3a05103496c1, topicName=鼻粘膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Wed Aug 08 09:09:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041983, encodeId=1669204198376, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103432, encryptionId=987b103432fe, topicName=鼻喷雾剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 01 09:09:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690991, encodeId=73001690991bd, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Thu Feb 28 02:09:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804343, encodeId=7b041804343c9, content=<a href='/topic/show?id=72e4e688685' target=_blank style='color:#2F92EE;'>#糠酸莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76886, encryptionId=72e4e688685, topicName=糠酸莫米松)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Sat Jul 14 07:09:00 CST 2018, time=2018-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608815, encodeId=5d0916088150a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 12 11:09:00 CST 2018, time=2018-05-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1676073, encodeId=95c616e60734c, content=<a href='/topic/show?id=3e7c8e9884c' target=_blank style='color:#2F92EE;'>#莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87988, encryptionId=3e7c8e9884c, topicName=莫米松)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b227313875, createdName=listen327, createdTime=Tue Oct 23 21:09:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994937, encodeId=9083199493ee4, content=<a href='/topic/show?id=3a05103496c1' target=_blank style='color:#2F92EE;'>#鼻粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103496, encryptionId=3a05103496c1, topicName=鼻粘膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Wed Aug 08 09:09:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041983, encodeId=1669204198376, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103432, encryptionId=987b103432fe, topicName=鼻喷雾剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 01 09:09:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690991, encodeId=73001690991bd, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Thu Feb 28 02:09:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804343, encodeId=7b041804343c9, content=<a href='/topic/show?id=72e4e688685' target=_blank style='color:#2F92EE;'>#糠酸莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76886, encryptionId=72e4e688685, topicName=糠酸莫米松)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Sat Jul 14 07:09:00 CST 2018, time=2018-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608815, encodeId=5d0916088150a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 12 11:09:00 CST 2018, time=2018-05-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1676073, encodeId=95c616e60734c, content=<a href='/topic/show?id=3e7c8e9884c' target=_blank style='color:#2F92EE;'>#莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87988, encryptionId=3e7c8e9884c, topicName=莫米松)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b227313875, createdName=listen327, createdTime=Tue Oct 23 21:09:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994937, encodeId=9083199493ee4, content=<a href='/topic/show?id=3a05103496c1' target=_blank style='color:#2F92EE;'>#鼻粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103496, encryptionId=3a05103496c1, topicName=鼻粘膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Wed Aug 08 09:09:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041983, encodeId=1669204198376, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103432, encryptionId=987b103432fe, topicName=鼻喷雾剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 01 09:09:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690991, encodeId=73001690991bd, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Thu Feb 28 02:09:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804343, encodeId=7b041804343c9, content=<a href='/topic/show?id=72e4e688685' target=_blank style='color:#2F92EE;'>#糠酸莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76886, encryptionId=72e4e688685, topicName=糠酸莫米松)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Sat Jul 14 07:09:00 CST 2018, time=2018-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608815, encodeId=5d0916088150a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 12 11:09:00 CST 2018, time=2018-05-12, status=1, ipAttribution=)]
    2019-02-28 guoyibin
  5. [GetPortalCommentsPageByObjectIdResponse(id=1676073, encodeId=95c616e60734c, content=<a href='/topic/show?id=3e7c8e9884c' target=_blank style='color:#2F92EE;'>#莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87988, encryptionId=3e7c8e9884c, topicName=莫米松)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b227313875, createdName=listen327, createdTime=Tue Oct 23 21:09:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994937, encodeId=9083199493ee4, content=<a href='/topic/show?id=3a05103496c1' target=_blank style='color:#2F92EE;'>#鼻粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103496, encryptionId=3a05103496c1, topicName=鼻粘膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Wed Aug 08 09:09:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041983, encodeId=1669204198376, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103432, encryptionId=987b103432fe, topicName=鼻喷雾剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 01 09:09:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690991, encodeId=73001690991bd, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Thu Feb 28 02:09:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804343, encodeId=7b041804343c9, content=<a href='/topic/show?id=72e4e688685' target=_blank style='color:#2F92EE;'>#糠酸莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76886, encryptionId=72e4e688685, topicName=糠酸莫米松)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Sat Jul 14 07:09:00 CST 2018, time=2018-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608815, encodeId=5d0916088150a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 12 11:09:00 CST 2018, time=2018-05-12, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1676073, encodeId=95c616e60734c, content=<a href='/topic/show?id=3e7c8e9884c' target=_blank style='color:#2F92EE;'>#莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87988, encryptionId=3e7c8e9884c, topicName=莫米松)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31b227313875, createdName=listen327, createdTime=Tue Oct 23 21:09:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994937, encodeId=9083199493ee4, content=<a href='/topic/show?id=3a05103496c1' target=_blank style='color:#2F92EE;'>#鼻粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103496, encryptionId=3a05103496c1, topicName=鼻粘膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Wed Aug 08 09:09:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2041983, encodeId=1669204198376, content=<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103432, encryptionId=987b103432fe, topicName=鼻喷雾剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Jul 01 09:09:00 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690991, encodeId=73001690991bd, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Thu Feb 28 02:09:00 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1804343, encodeId=7b041804343c9, content=<a href='/topic/show?id=72e4e688685' target=_blank style='color:#2F92EE;'>#糠酸莫米松#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76886, encryptionId=72e4e688685, topicName=糠酸莫米松)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Sat Jul 14 07:09:00 CST 2018, time=2018-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608815, encodeId=5d0916088150a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 12 11:09:00 CST 2018, time=2018-05-12, status=1, ipAttribution=)]